PAR paradigm biopharmaceuticals limited..

research reports and media, page-3016

  1. 4,901 Posts.
    lightbulb Created with Sketch. 7628
    Hamman, while one must do their own research...that's all I've been doing for the last 2 and a bit years.....

    • Science
    • Patients
    • Company

    ...I still have plenty to do and read and of course learn....BUT while I personally do a stack of research, that doesn't mean we ARE going to be successful 100%. There is still risk.

    But in all that time I have only come across scares/real possible negatives a handful of times and each and every time they have been quashed one way or the other (from what I ascertain).

    If you ask me whether I think the results are good..well from the above bullet points, yes. I think they are. Go through any of my major posts and you will get a sense of why I think that.

    In a nutshell what do we compare ourselves to?


    Opioids - horrid, addictive, dangerous

    NASAID - Terrible, can lead to major gut problems, liver problems and a raft of side effects

    Corticosteroids? Terrible, can increase rate of joint failure, do not use these for prolonged period despite the allure of instant pain relief for a few weeks.

    Stem Cells - Too new, need clinical trials to prove this and longitudinal studies to check...its hit and miss still, the tech will get better but its a way off. Quite expensive for the moment too.





    Granted that for pain relief there isn't a lot one can do and do it safely, I feel sorry for those that have no choice.

    Surgery eventually becomes the only option.

    With some 75% getting at least 25% efficacy and circa 88% getting some pain relief, to do that safely are results beyond imagination if we get through P3 and there are no serious AE's.


    Then there is DMOAD.






    DYOR


    Last edited by Mozzarc: 04/07/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
-0.020(4.55%)
Mkt cap ! $166.9M
Open High Low Value Volume
44.5¢ 44.5¢ 41.5¢ $271.6K 637.8K

Buyers (Bids)

No. Vol. Price($)
2 5960 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 3696 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.